Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Antidepressants and Suicide Risk: Using the Evidence to Separate Fact from Fiction
Track:
Educational Sessions
Program Code: 202-L01
Date: Monday, December 8, 2008
Time: 2:00 PM to 4:00 PM EST
Location:
S230B
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Steven Stoner, PharmD, BCPP, Clinical Professor, University of Missouri-Kansas City School of Pharmacy
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Steven Stoner, PharmD, BCPP, Clinical Professor, University of Missouri-Kansas City School of Pharmacy
SPEAKER:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Steven Stoner, PharmD, BCPP, Clinical Professor, University of Missouri-Kansas City School of Pharmacy- Compare the clinical outcomes related to suicidality and suicide rates from recent antidepressant trials assessing the effectiveness of depression treatment in children, adolescents, and adults.
- Describe the role of antidepressants and adjunctive pharmacotherapeutic agents for the treatment of depression including necessary monitoring.
- Explain the clinical impact on depression treatment and suicide rates before and after the introduction of the U.S. Food and Drug Administration's mandated suicidality warnings.
- Identify risk factors associated with use of antidepressants and increased suicidal behavior and ideation.